trigger - pulmonary circulation disorders Flashcards

1
Q

PE type resulting from long bone fractures

A

fat PEs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

MC sign and MC symptom of PE

A

tachypnea and dyspnea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

wells criteria of 5

A

moderate risk

remember:
>6 = high
2-6 = intermediate
<2 = low

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the next step after determining that the wells score is “low”

A

use PERC rules! if even one is positive you MUST get D-dimer!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

if a patient is 67 what is their expected D-dimer

A

below 670ng/mL

if patient is above 50, use the equation:
age x 10ng/mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

caution with metformin

A

CTA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what imaging is used for pregnant patients with suspected PE

A

VQ scans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

area of lung oligemia - usually from complete lobar artery obstruction

A

westermarks sign

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

dome-shaped dense opacification in the periphery of the lung. indicative of pulmonary infarction

A

hamptons hump

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the risk stratification for high risk PE (massive)

A

ANY of the following:
- SBP<90 for >15 min
- drop in SBP >40 mmHg below basline
- hypotension requiring vasopressors
- cardiac arrest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

risk stratification for intermediate risk PE

A
  • signs of R sided HF
  • elevated trop or BNP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what should you NOT do in PE patients d/t risk of right sided HF

A

give excess IV fluids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

binds to and accelerates activity of antithrombin

A

unfrac heparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

obtain aPTT every 6 hours during tx

A

unfrac heparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

this anticoagulant is reserved for unstable patients or pateints with severe renal insufficiency

A

unfrac heparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

dose: 80 units/kg/dose IV then 18units/kg/hour (max 2000)

A

unfrac heparin

16
Q

preferred in pts who cant take oral anticoags

17
Q

requires monitoring in obese and underweight patients (<45kg) or patients with renal impairment

18
Q

BID then QD after 21 days

A

rivaroxaban (xarelto)

19
Q

which anticoags require bridging

A
  • dabigatran (pradaxa) - 5-10 days w/UFH or LMWH
  • warfarin - w/LMWH until INR is 2-3
20
Q

anticoag with once daily SQ dosing

A

fondaparinux (arixtra)

21
Q

pt has intermediate risk with elevated trop and BNP with persistent hypoxia. what is treatment?

A

tPA!

indicated in high risk
indicated in intermediate w/ elevated trop OR BNP OR hypoxemia w/ distress

22
Q

pt has an active bleed that prevents use of anticoagulation. what is the treatment for their PE?

A

IVC filter

23
Q

what are the WHO pulm HTN classifications

A

class 1: idiopathic, hereditary, drug induced, cong HD, CTD, or HIV associated
class 2: d/t left sided Heart disease
class 3: d/t lung disease/hypoxia
class 4: d/t chronic thromboembolic pulm HTN
class 5: multiple causes (ex. sarcoidosis)

24
cyanosis, hepatomegaly, JVD and accentuated P2 sound.
PE findings of pulm HTN also see: tricusoid regurg murmur 3rd kentucky heart sound lower extremity edema
25
what pulmonary capillary wedge pressure is indicative of left sided heart disease
16 or more confirm with left heart cath!
26
a drop of mPAP of 10-40mmHg after injection of vasodilator
vasodilator response
27
CCB such as high dose diltiazem and nifedipine used as treatment
pulmonary HTN NYHA class 1-3 with vasoreactive disease
28
produced in the cells that line the heart and lungs; when released results in vasoconstriction
endothelin
29
sidenafil and tadalafil are what types of meds
PDE 5 inhibitors
30
monotherapy is considered for treatment
non-vasoreactive NYHA stage 1 pulm HTN
31
combination therapy of endothelin antgonists and PDE5 inhibitors add guanylate cyclase stimulators or oral prostacyclin receptor agonists if uncontrolled
management for non vasoreactive NYHA stage 2/3 pulm HTN
32
Add on parenteral prostanoid to oral combination therapy
non-vasoreactive NYHA stage IV pulm HTN